Exploring ‘food noise’: Study sheds light on eating thoughts and obesity treatment breakthroughs

Study delves into the concept of ‘food noise,’ referring to persistent thoughts about eating, and assesses its impact on eating behaviors and obesity treatments. It explores how GLP-1RAs, a class of drugs used for weight management, might influence food cue reactivity, potentially offering new insights into obesity treatment and the psychological aspects of eating behaviors.

BetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placement | Psychedelic Invest

BetterLife Pharma Inc. (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce

September 5, 2023

Tier-1 Medical Journal Publishes Final Results Of Phase 3 MDMA-Assisted Therapy Study

The psychedelic sector received a material boost today, when late this morning, final MAPP2 MDMA-assisted therapy results were published in Nature Medicine. With positive efficacy

September 14, 2023

New study finds maternal vaccine and monoclonal antibody effective against RSV in infants

The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy.

January 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.